Compound: altretamine
SMILES: n1c(nc(N(C)C)nc1N(C)C)N(C)C
InChIKey: UUVWYPNAQBNQJQ-UHFFFAOYSA-N
Synonyms: altretamine, 645-05-6, HEXAMETHYLMELAMINE, Hexalen, Hexastat, Hemel, Altretamina, Melamine, hexamethyl-, Altretaminum, ENT 50852, 2,4,6-Tris(dimethylamino)-s-triazine, NCI-C50259, 2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine, NSC 13875, NSC-13875, s-Triazine, 2,4,6-tris(dimethylamino)-, 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-, DTXSID4022579, Q8BIH59O7H, NSC13875, DTXCID902579, CHEBI:24564, Hexinawas, ENT-50852, RefChem:556262, L01XX03, RB-1515, WR-95704, N,n,n',N\"N\"-hexamethyl-1,3,5,-triazine-2,4,6,-triamine, N,N,N',N',N\",N\"-hexamethyl-1,3,5-triazine-2,4,6-triamine, 211-428-4, Hexamethylamine, 2,4,6-Tris(dimethylamino)-1,3,5-triazine, N2,N2,N4,N4,N6,N6-hexamethyl-1,3,5-triazine-2,4,6-triamine, Altretaminum [INN-Latin], NC 195, HMM, Altretamine (Hexalen), HTM, HXM, MFCD00549245, MLS000069621, N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine, SMR000058181, Altretamine-d18, NCGC00015100-02, N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine, ENT-50852;RB-1515;WR-95704, Altretamina [INN-Spanish], CAS-645-05-6, Hexalen (TN), CCRIS 5492, SR-01000000117, Hexalen [Antineoplastic], Altretamine (USP/INN), EINECS 211-428-4, UNII-Q8BIH59O7H, BRN 0195058, AI3-50852, 645-05-6 (free base), HSDB 7559, Altretamine [USAN:USP:INN:BAN], KB-913, Altretamine (Standard), Spectrum_001308, ALTRETAMINE [MI], Opera_ID_1095, Prestwick0_000946, Prestwick1_000946, Prestwick2_000946, Prestwick3_000946, Spectrum2_000907, Spectrum3_000951, Spectrum4_001064, Spectrum5_001092, ALTRETAMINE [INN], Lopac-A-8723, ChemDiv2_005185, ALTRETAMINE [HSDB], ALTRETAMINE [USAN], 2,4, 6-Tris(dimethylamino)-1,3,5-triazine, A 8723, ALTRETAMINE [VANDF], Cambridge id 5148727, cid_2123, SCHEMBL4206, ALTRETAMINE [MART.], CHEMBL1455, Lopac0_000083, ALTRETAMINE [USP-RS], ALTRETAMINE [WHO-DD], BSPBio_000912, KBioGR_001388, KBioSS_001788, MLS001076123, DivK1c_000772, SPECTRUM1503065, SPBio_000754, SPBio_003071, BPBio1_001004, GTPL7112, orb1309268, BDBM37631, HMS502G14, HY-B0181R, KBio1_000772, KBio2_001788, KBio2_004356, KBio2_006924, KBio3_002042, ALTRETAMINE [ORANGE BOOK], NINDS_000772, HMS1383L15, HMS1570N14, HMS1922C05, HMS2090G17, HMS2092H16, HMS2097N14, HMS2234F09, HMS3259I20, HMS3260A08, HMS3372H17, HMS3654H11, HMS3714N14, HMS5079H05, Pharmakon1600-01503065, ALTRETAMINE [USP MONOGRAPH], 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N',N'-hexamethyl-, CCG-2238, HY-B0181, QCA88669, 2,6-Tris(dimethylamino)-s-triazine, Tox21_110085, Tox21_202784, Tox21_500083, EBC-03618, MSK164119, NSC758231, s1278, STK749184, s-Triazine,4,6-tris(dimethylamino)-, AKOS001729401, Tox21_110085_1, 1,3,5-Tris(dimethylamino)-s-triazine, CS-2061, DB00488, FA17334, KS-5247, LP00083, NC00595, NSC-758231, SB73671, SDCCGSBI-0050071.P004, IDI1_000772, IDI1_003900, NCGC00015100-01, NCGC00015100-03, NCGC00015100-04, NCGC00015100-05, NCGC00015100-06, NCGC00015100-07, NCGC00015100-08, NCGC00015100-09, NCGC00015100-10, NCGC00015100-11, NCGC00015100-12, NCGC00015100-14, NCGC00015100-15, NCGC00015100-23, NCGC00021216-03, NCGC00021216-04, NCGC00021216-05, NCGC00021216-06, NCGC00021216-07, NCGC00260330-01, NCGC00260768-01, AC-12006, CAS-654-05-6, NCI60_000871, ST086739, 2,6-Tris(dimethylamino)-1,3,5-triazine, SBI-0050071.P003, DB-054676, AB00052308, EU-0100083, NS00006180, SW102053-5, C76020, D02841, EN300-122382, AB00052308-16, AB00052308-17, AB00052308-18, AB00052308_19, AB00052308_20, Q415242, WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1, 2,4,6-Tris(dimethylamino)-1,3,5-triazine, 96%, SR-01000000117-2, SR-01000000117-4, SR-01000000117-6, BRD-K67043667-001-04-1, BRD-K67043667-001-15-7, BRD-K67043667-001-25-6, BRD-K67043667-001-26-4, Z57931197, [4,6-bis(dimethylamino)(1,3,5-triazin-2-yl)]dimethylamine, 1,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-, Altretamine, United States Pharmacopeia (USP) Reference Standard, 1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'', N''-hexamethyl-, InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
Theoretical properties:
molecular_formula: C9H18N6
molecular_weight: 210.28 g/mol
exact_mass: 210.15929460 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 6
rotatable_bond_count: 3
heavy_atom_count: 15
topological_polar_surface_area: 48.4 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
physical_state: Needles from absolute ethanol
color: Needles from absolute ethanol
solubility: Insoluble (NTP, 1992)
Descriptions:
pubchem: Altretamine can cause developmental toxicity and male reproductive toxicity according to state or federal government labeling requirements.
chembl: ALTRETAMINE is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Altretamine (trade name Hexalen), also called hexamethylmelamine, is an antineoplastic agent. It was approved by the U.S. FDA in 1990.